FIGO good practice recommendations on modifiable causes of iatrogenic preterm birth
| Autor: | Bo Jacobsson, Ben W.J. Mol, Catalina M Valencia |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
business.industry Obstetrics and Gynecology Burroughs Wellcome General Medicine Norwegian Special Interest Group Precision medicine language.human_language Family medicine language medicine Genomic medicine Steering group business Good practice health care economics and organizations Preterm delivery |
| Zdroj: | International Journal of Gynecology & Obstetrics |
| ISSN: | 1879-3479 0020-7292 |
| Popis: | Funding Information: Catalina M. Valencia reports no conflicts of interest. Ben W. Mol reports an investigator grant from NHMRC; consultancy for ObsEva; and research funding from Guerbet, Ferring, and Merck KGaA. Bo Jacobbson reports research grants from Swedish Research Council, Norwegian Research Council, March of Dimes, Burroughs Wellcome Fund and the US National Institute of Health; clinical diagnostic trials on NIPT with Ariosa (completed), Natera (ongoing), Vanadis (completed) and Hologic (ongoing) with expendidures reimbused per patient; clinical probiotic studies with product provided by FukoPharma (ongoing, no funding) and BioGaia (ongoing; also provided a research grant for the specific study); collaboration in IMPACT study where Roche, Perkin Elmer and Thermo Fisher provided reagents to PLGF analyses; coordination of scientific conferences and meetings with commercial partners as such as NNFM 2015, ESPBC 2016 and a Nordic educational meeting about NIPT and preeclampsia screening. Bo Jacobbson is also Chair of the FIGO Working Group for Preterm Birth and the European Association of Perinatal Medicine's special interest group of preterm delivery; steering group member of Genomic Medicine Sweden; chairs the Genomic Medicine Sweden complex diseases group; and is Swedish representative in the Nordic Society of Precision Medicine. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text